Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311455574> ?p ?o ?g. }
- W4311455574 endingPage "1127" @default.
- W4311455574 startingPage "1117" @default.
- W4311455574 abstract "Adverse drug events (ADEs) are regarded as the most essential therapeutic issue during management of drug-resistant tuberculosis (DR-TB) due to the long duration of therapy and concurrent use of many second-line medications. This study aimed to determine the incidence and factors associated with ADEs among patients receiving DR-TB treatment at Mulago hospital in Uganda.A retrospective cohort study was conducted among 417 DR-TB patient records at Mulago National Referral Hospital from January 2013 to December 2020. Using the data abstraction form, data were collected on socio-demographic and clinical factors, adverse drug events and treatment follow-up time. Data were double entered in Epi data version 3.2 and later exported to Stata version 14.0 for analysis. The incidence rate of adverse drug events was computed using number of cases of ADE divided by overall patient follow-up time. Poisson regression model was used to determine the factors associated with ADEs. The predictors were considered significant at if p< 0.05.The overall incidence was 5.56 ADEs per 100 person months (95% confidence interval (CI) 5.01, 6.15). Treatment regimens containing an aminoglycoside (incident rate ratio (IRR) 1.106, 95% CI 1.005-1.216 p=0.0391), linezolid (IRR 1.145, 95% CI 1.008-1.229 p = 0.037) or pyrazinamide (IRR 1.226, 95% CI 1.072-1.401 p = 0.003) and the treatment duration (in months) (IRR 1.005, 95% CI 1.001-1.010 p = 0.042) were associated with ADEs.Regimens containing aminoglycosides, linezolid, or pyrazinamide and increase in treatment duration (months) were associated with an increased risk of ADEs. Clinicians should quickly adopt all oral shorter treatment regimens to obviate the need for aminoglycosides and reduce exposure duration." @default.
- W4311455574 created "2022-12-26" @default.
- W4311455574 creator A5014308193 @default.
- W4311455574 creator A5014635530 @default.
- W4311455574 creator A5033249386 @default.
- W4311455574 creator A5058072957 @default.
- W4311455574 date "2022-12-01" @default.
- W4311455574 modified "2023-09-30" @default.
- W4311455574 title "Incidence and Predictors of Adverse Drug Events Among People Receiving Drug Resistant Tuberculosis Treatment in Uganda: 8-Year Retrospective Cohort Study" @default.
- W4311455574 cites W1765287762 @default.
- W4311455574 cites W1949076674 @default.
- W4311455574 cites W1973582459 @default.
- W4311455574 cites W1997433600 @default.
- W4311455574 cites W2024416030 @default.
- W4311455574 cites W2024962518 @default.
- W4311455574 cites W2033184553 @default.
- W4311455574 cites W2058466807 @default.
- W4311455574 cites W2062485984 @default.
- W4311455574 cites W2109028417 @default.
- W4311455574 cites W2154074073 @default.
- W4311455574 cites W2336000508 @default.
- W4311455574 cites W2405929430 @default.
- W4311455574 cites W2460282935 @default.
- W4311455574 cites W2535245771 @default.
- W4311455574 cites W2603888074 @default.
- W4311455574 cites W2756619582 @default.
- W4311455574 cites W2799648329 @default.
- W4311455574 cites W2884078617 @default.
- W4311455574 cites W2943459292 @default.
- W4311455574 cites W2947164752 @default.
- W4311455574 cites W2962752469 @default.
- W4311455574 cites W3010945518 @default.
- W4311455574 cites W3015773895 @default.
- W4311455574 cites W3108150642 @default.
- W4311455574 cites W3117957592 @default.
- W4311455574 cites W3119728664 @default.
- W4311455574 cites W3121225209 @default.
- W4311455574 cites W3134442205 @default.
- W4311455574 cites W3165577352 @default.
- W4311455574 doi "https://doi.org/10.2147/tcrm.s381800" @default.
- W4311455574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36544865" @default.
- W4311455574 hasPublicationYear "2022" @default.
- W4311455574 type Work @default.
- W4311455574 citedByCount "2" @default.
- W4311455574 countsByYear W43114555742023 @default.
- W4311455574 crossrefType "journal-article" @default.
- W4311455574 hasAuthorship W4311455574A5014308193 @default.
- W4311455574 hasAuthorship W4311455574A5014635530 @default.
- W4311455574 hasAuthorship W4311455574A5033249386 @default.
- W4311455574 hasAuthorship W4311455574A5058072957 @default.
- W4311455574 hasBestOaLocation W43114555741 @default.
- W4311455574 hasConcept C120665830 @default.
- W4311455574 hasConcept C121332964 @default.
- W4311455574 hasConcept C126322002 @default.
- W4311455574 hasConcept C142724271 @default.
- W4311455574 hasConcept C167135981 @default.
- W4311455574 hasConcept C167704817 @default.
- W4311455574 hasConcept C187212893 @default.
- W4311455574 hasConcept C197934379 @default.
- W4311455574 hasConcept C201903717 @default.
- W4311455574 hasConcept C2780283434 @default.
- W4311455574 hasConcept C2781069245 @default.
- W4311455574 hasConcept C2908647359 @default.
- W4311455574 hasConcept C44249647 @default.
- W4311455574 hasConcept C61511704 @default.
- W4311455574 hasConcept C71924100 @default.
- W4311455574 hasConcept C72563966 @default.
- W4311455574 hasConcept C73269764 @default.
- W4311455574 hasConcept C99454951 @default.
- W4311455574 hasConceptScore W4311455574C120665830 @default.
- W4311455574 hasConceptScore W4311455574C121332964 @default.
- W4311455574 hasConceptScore W4311455574C126322002 @default.
- W4311455574 hasConceptScore W4311455574C142724271 @default.
- W4311455574 hasConceptScore W4311455574C167135981 @default.
- W4311455574 hasConceptScore W4311455574C167704817 @default.
- W4311455574 hasConceptScore W4311455574C187212893 @default.
- W4311455574 hasConceptScore W4311455574C197934379 @default.
- W4311455574 hasConceptScore W4311455574C201903717 @default.
- W4311455574 hasConceptScore W4311455574C2780283434 @default.
- W4311455574 hasConceptScore W4311455574C2781069245 @default.
- W4311455574 hasConceptScore W4311455574C2908647359 @default.
- W4311455574 hasConceptScore W4311455574C44249647 @default.
- W4311455574 hasConceptScore W4311455574C61511704 @default.
- W4311455574 hasConceptScore W4311455574C71924100 @default.
- W4311455574 hasConceptScore W4311455574C72563966 @default.
- W4311455574 hasConceptScore W4311455574C73269764 @default.
- W4311455574 hasConceptScore W4311455574C99454951 @default.
- W4311455574 hasLocation W43114555741 @default.
- W4311455574 hasLocation W43114555742 @default.
- W4311455574 hasLocation W43114555743 @default.
- W4311455574 hasLocation W43114555744 @default.
- W4311455574 hasOpenAccess W4311455574 @default.
- W4311455574 hasPrimaryLocation W43114555741 @default.
- W4311455574 hasRelatedWork W2118157559 @default.
- W4311455574 hasRelatedWork W2366643898 @default.
- W4311455574 hasRelatedWork W2599341543 @default.
- W4311455574 hasRelatedWork W2600529727 @default.
- W4311455574 hasRelatedWork W2889061495 @default.